| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| acetylcysteine | aminoacylase-1 | small molecule | NA | drugbank | Disease Management[MeSHID:D019468] Drug Overdose[MeSHID:D062787] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Liver diseases[MeSHID:D008107] |
NA | approved,investigational | substrate |
| acetylcysteine | inhibitor of nuclear factor kappa-b kinase subunit alpha | small molecule | NA | drugbank | Disease Management[MeSHID:D019468] Drug Overdose[MeSHID:D062787] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Liver diseases[MeSHID:D008107] |
NA | approved,investigational | inhibitor |
| acetylcysteine | glutamate receptor ionotropic, nmda 1 | small molecule | NA | drugbank | Disease Management[MeSHID:D019468] Drug Overdose[MeSHID:D062787] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Liver diseases[MeSHID:D008107] |
NA | approved,investigational | activator |
| acetylcysteine | glutamate receptor ionotropic, nmda 2a | small molecule | NA | drugbank | Disease Management[MeSHID:D019468] Drug Overdose[MeSHID:D062787] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Liver diseases[MeSHID:D008107] |
NA | approved,investigational | activator |
| acetylcysteine | glutamate receptor ionotropic, nmda 2b | small molecule | NA | drugbank | Disease Management[MeSHID:D019468] Drug Overdose[MeSHID:D062787] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Liver diseases[MeSHID:D008107] |
NA | approved,investigational | activator |
| acetylcysteine | glutamate receptor ionotropic, nmda 2d | small molecule | NA | drugbank | Disease Management[MeSHID:D019468] Drug Overdose[MeSHID:D062787] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Liver diseases[MeSHID:D008107] |
NA | approved,investigational | activator |
| acetylcysteine | glutamate receptor ionotropic, nmda 3a | small molecule | NA | drugbank | Disease Management[MeSHID:D019468] Drug Overdose[MeSHID:D062787] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Liver diseases[MeSHID:D008107] |
NA | approved,investigational | activator |
| acetylcysteine | glutathione synthetase | small molecule | NA | drugbank | Disease Management[MeSHID:D019468] Drug Overdose[MeSHID:D062787] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Liver diseases[MeSHID:D008107] |
NA | approved,investigational | stimulator |
| acetylcysteine | inhibitor of nuclear factor kappa-b kinase subunit beta | small molecule | NA | drugbank | Disease Management[MeSHID:D019468] Drug Overdose[MeSHID:D062787] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Liver diseases[MeSHID:D008107] |
NA | approved,investigational | inhibitor |
| acetylcysteine | cystine/glutamate transporter | small molecule | NA | drugbank | Disease Management[MeSHID:D019468] Drug Overdose[MeSHID:D062787] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Liver diseases[MeSHID:D008107] |
NA | approved,investigational | activator |
| acetylcysteine | napqi (n-acetyl-p-benzoquinone imine) | small molecule | NA | drugbank | Disease Management[MeSHID:D019468] Drug Overdose[MeSHID:D062787] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Liver diseases[MeSHID:D008107] |
NA | approved,investigational | reducer |
| click here to return to the previous page | ||||||||